CARROLL J MARTIN
SEC insider (Form 3/4/5 filer). CIK 0001279901. Director at Esperion Therapeutics, Inc. (ESPR) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 13, 2026. Located in ANN ARBOR, MI.
Companies CARROLL J MARTIN has filed insider reports for
- Esperion Therapeutics, Inc. (ESPR): Director
- Catalent, Inc. (CTLT): Director
CARROLL J MARTIN
CIK: 0001279901
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (40.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jul 13, 2026ESPR
Esperion Therapeutics, Inc.
DispositionDirect177.5K shares- - May 28, 2026ESPR
Esperion Therapeutics, Inc.
AwardDirect79.9K shares- - May 29, 2025ESPR
Esperion Therapeutics, Inc.
AwardDirect33K shares- - Dec 18, 2024CTLT
Catalent, Inc.
DispositionDirect32.7K shares- - Oct 30, 2024CTLT
Catalent, Inc.
AwardDirect4.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 13, 2026 |  ESPR Esperion Therapeutics, Inc. | Disposition | 177,523 | - | $0 | Direct |
| May 28, 2026 | ESPR Esperion Therapeutics, Inc. | Award | 79,873 | - | $0 | Direct |
| May 29, 2025 | ESPR Esperion Therapeutics, Inc. | Award | 33,000 | - | - | Direct |
| Dec 18, 2024 |  CTLT Catalent, Inc. | Disposition | 32,734 | - | $0 | Direct |
| Oct 30, 2024 | CTLT Catalent, Inc. | Award | 4,663 | - | $0 | Direct |
1-5 of 5 transactions